American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: PS205
Title: Pro-Hemostatic Drugs: Is There a Role in Trauma Resuscitation?
Date and Time of Session: Tuesday, October 24: 8:00 am - 9:30 am
Description: Patients with severe hemorrhage and severe tissue injury can present with acute coagulopathy of trauma shock (ACOTS). This group of patients have a 4-fold increase in mortality. Prompt recognition and management is of the essence. The session would bring in experts from different backgrounds and focus on issues such as: a.Early recognition of ACOTS b. Role of pre-emptive tranexamic acid (TXA) versus Thromboelastography/Rotational Thromboelastometry (TEG/ROTEM) directed therapy, c. Are we done with Factor VIIa?, and d. Any new wonder drugs?
CME Credit Hours: 1.5
Webcast Package Available: Yes
Audio Package Available: Yes
Trauma / Critical Care (TRA), General Surgery (GEN), Neurosurgery (NEU)
Credit to Address ACS Accreditation/Verification Requirements:
Sponsored By:
Committee on Trauma
Program Participants:
Mitchell J. Cohen, MD, FACS
Martin A. Schreiber, MD, FACS
Speaker TXA: Controversies, Uses and Data
Michael William Cripps, MD MSCS FACS
Speaker Viscoelastic Goal Directed Resuscitation after Injury
Ernest E. Moore, MD, FACS
Speaker Prothrombin Complex Concentrates in Trauma: Uses, Controversies and Data
Bellal Joseph, MD, FACS
Speaker Factor VII and Other Adjuncts: What is Available for the Treatment of Bleeding after Trauma
Ryan A. Lawless, MD